Our Ireland Site

Perrigo Company’s global headquarters are in Dublin, Ireland.

In December 2013, Perrigo acquired Elan Pharmaceuticals plc, a leading Irish pharmaceutical company with a 40-year history of developing new drug technologies on a global basis. Perrigo Company and Elan have been combined under a new company incorporated in Ireland and have adopted the global name Perrigo Company plc.

The combined company establishes a diversified platform that will position Perrigo well for further expansion. Perrigo’s core business and operational strengths, combined with the royalty stream from Tysabri®, a blockbuster product used to treat multiple sclerosis that generated revenues of US$1.6 billion in 2012, the company is well positioned to pursue an accelerated global growth trajectory.